Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...

Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

When you weigh nearly 20 stone, small everyday things are fraught with anxiety. There are so many worries regular-sized ...

Novo Nordisk also sells semaglutide as Ozempic for diabetes in the UK ... and is currently available in the original singe-dose pen-injector format. Mounjaro has already been launched in other ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Patients waiting for NHS weight loss jabs are buying potentially unsafe jabs online or from gyms and beauty salons ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.